“We really position business development as a team sport at the company.”
Kate Falberg, Chief Financial Officer, Jazz Pharmaceuticals plc, at its breakout session, J.P. Morgan Healthcare Conference

“You will continue to see our European shareholder base increase over time. I think you’re seeing a resurgence in interest from the more generalist European fund managers.”
Rebecca Peterson, senior vice president of corporate communications, Alkermes plc, on a new share offering directed at two Invesco Perpetual funds managed by UK investment management firm Invesco Ltd.

“Our findings are important for our basic understanding of how this most common cancer arises. The results of this study underpin the view that, for a cancer treatment to be effective, it needs to hit a target that is present in every cancer cell. You can’t ignore the clonal diversity of cancers.”
Mel Greaves, professor of cell biology at the Institute for Cancer Research in Sutton, UK

“Our job is to convert technical leadership into a position of industrial leadership. Technical advantage doesn’t always lead to competitive advantage.”
Randal J. Kirk, chairman and CEO, Intrexon Corp.

“Life science is a business that requires very difficult decisions. Whoever makes those difficult decisions will win.”
Frank Yu, founder and CEO of Hong Kong private equity fund Themes Investment Partners and investment firm Ally Bridge Group